CXCL13 and multiple sclerosis: CXCL13 expression has been correlated with disease exacerbation and unfavorable prognosis in multiple sclerosis, Sjögren's (43), myasthenia gravis, and SLE, and CXCL13 has been proposed as a biomarker for diagnosis and progression in these conditions (44).